文献速递头颈US

超声引导下空芯针活检作为颈部淋巴结病变一线活检方法的可行性、有效性与安全性

Feasibility, efficacy, and safety of core needle biopsy as a first-line method for cervical lymphadenopathy.
PubMed 文献 · Eur Radiol · 2024-11-06

这项回顾性队列研究纳入以超声引导下空芯针活检作为非甲状腺来源颈部淋巴结病变一线活检方法的连续患者,采用同轴技术,对小的高危淋巴结选择性使用倾斜和水分离技术。结果无诊断结论率0.7%、不确定结果率3.4%、无结论率4.1%,技术成功率99.3%,无主要并发症,轻微并发症7例(0.6%)。作者认为该法技术可行、有效且安全,对恶性淋巴结诊断准确率高。

要点

  • 无诊断结论率0.7%、不确定结果率3.4%,无结论率合计4.1%。
  • 以恶性结果为标准,敏感度96.2%、特异度100%、准确率97.8%。
  • 技术成功率99.3%,无主要并发症,轻微并发症为无症状血肿7例(0.6%)。

核心结论

  • 超声引导下空芯针活检作为非甲状腺来源颈部淋巴结病变的一线活检方法技术可行、有效且安全,对恶性淋巴结病变诊断准确率高。

研究设计与样本

  • 回顾性队列研究,纳入以超声引导下空芯针活检作为推测非甲状腺来源颈部淋巴结一线活检方法的连续患者;常规采用同轴空芯针活检技术,对小的高危淋巴结选择性采用倾斜和水分离空芯针活检技术。

诊断标准与关键数值

  • 无诊断结论率0.7%、不确定结果率3.4%、无结论率4.1%;标准1(恶性结果)时敏感度96.2%、特异度100%、准确率97.8%;标准2(恶性或不确定结果)时敏感度、特异度、准确率均为99.8%;技术成功率99.3%。

临床应用与阅片要点

  • 作者认为超声引导下空芯针活检可作为颈部淋巴结病变的有效一线活检方法,将有助于恶性淋巴结的准确诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study aimed to determine the feasibility, diagnostic efficacy, and safety of ultrasound-guided core needle biopsy (CNB) as a first-line biopsy method for cervical lymphadenopathy of non-thyroid origin.

MATERIALS AND METHODS: This retrospective cohort study included consecutive patients with cervical lymphadenopathy in whom US-guided CNB was used as the first-line biopsy method for cervical lymph nodes (LNs) of presumed non-thyroid origin. The coaxial CNB technique was routinely used, while the tilting and hydrodissection CNB techniques were selectively employed for small high-risk LNs. The primary endpoint of this study was the diagnostic efficacy of CNB, evaluated by the rate of inconclusive results (nondiagnostic and indeterminate) and diagnostic accuracy (criterion 1: malignant results; criterion 2: malignant or indeterminate result). The secondary outcomes included the feasibility and safety of CNB, assessed based on the technical success rate and complication rate, respectively.

RESULTS: The rates of nondiagnostic, indeterminate, and inconclusive results were 0.7%, 3.4%, and 4.1%, respectively. The sensitivity, specificity, and accuracy of CNB for malignant LNs were 96.2%, 100%, and 97.8%, respectively, with criterion 1, and these values were all 99.8% with criterion 2. The technical success rate of CNB was 99.3%. There were no major complications and 7 cases (0.6%) of minor complications (asymptomatic hematomas).

CONCLUSION: CNB was technically feasible, effective, and safe as a first-line biopsy method for cervical lymphadenopathy of non-thyroid origin with high diagnostic accuracy for malignant nodal disease.

KEY POINTS: Question The role of US-guided CNB as a first-line biopsy method for cervical LNs has not yet been verified and established. Findings US-guided CNB, as a first-line method, demonstrated a high technical success rate and diagnostic accuracy for malignant nodes, with few minor complications. Clinical relevance US-guided CNB can be used as an effective first-line biopsy method for cervical lymphadenopathy and will enable accurate diagnosis of malignant LNs.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Jeong CY, Noh BJ, Na DG, et al. Feasibility, efficacy, and safety of core needle biopsy as a first-line method for cervical lymphadenopathy. Eur Radiol. 2024. PMID: 39500801. doi:10.1007/s00330-024-11174-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。